Home | Privacy | Contact    

Health Information About Gastrointestinal Tumors


Gastrointestinal stromal tumor - Wikipedia, the free encyclopedia
http://en.wikipedia.org/wiki/Gastrointestinal_stromal_tumor A gastrointestinal stromal tumor (GIST) is one of the most common mesenchymal tumors of the gastrointestinal tract (1-3% of all gastrointestinal malignancies). They ... more...
Gastrointestinal Stromal Tumors - Diseases & Conditions - Medscape ...
http://emedicine.medscape.com/article/179669-overview Gastrointestinal stromal tumors (GISTs) are the most common mesenchymal neoplasms of the gastrointestinal tract. more...
Carcinoid Tumors, Gastrointestinal: Information from Answers.com
http://www.answers.com/topic/carcinoid-tumors-gastrointestinal Key Terms: Adrenal gland, Cyanosis, Heart murmur, Hormone. Definition Gastrointestinal carcinoid tumors are rare malignancies in which cancer develops in hormone ... more...
Imaging in Gastrointestinal Stromal Tumors - Leiomyoma/Leiomyosarcoma
http://emedicine.medscape.com/article/369803-overview Gastrointestinal stromal tumors (GISTs) are a subset of GI mesenchymal tumors of varying differentiation. Previously, these tumors were classified as GI leiomyomas ... more...
Gastrointestinal Stromal Tumors - The Doctor's Doctor
http://www.thedoctorsdoctor.com/diseases/stromal_tumors_gi.htm Background. Gastrointestinal Stromal Tumors (GIST) are a rare but important group of tumors arising within the gastrointestinal tract. For many years, these tumors ... more...



Gastrointestinal Tumors News


gastrointestinal tumors - Bing News
IMPORTANT: Bing News RSS feed has moved!
Go to the new RSS page and renew your subscription.
read more...
AB Soars 72% as Cancer Drug Beats Pfizer's Sutent: Paris Mover
Feb. 2 (Bloomberg) -- AB Science SA soared 72 percent in Paris trading after a clinical trial showed the company's experimental cancer drug masitinib worked better than a Pfizer Inc. medicine on read more...
New Market Report:
GlobalData's clinical trial report, " read more...
FDA approves Novartis drug Gleevec® label recommending extending treatment to three years for certai
read more...
FDA approves Gleevec for expanded use in patients with rare
The U.S. Food and Drug Administration today granted Gleevec (imatinib) regular approval for use in adult patients following surgical removal of CD117-positive read more...